AbbVie's atogepant showed fewer side effects and greater efficacy than topiramate in a Phase 3 migraine prevention trial.

Stephanie Link of Hightower said Uber Technologies is her final trade. Brian Belski at BMO Capital Markets picked The ...

Alibaba's AI and retail innovations make it a top player in China's ETF market, attracting attention from thematic ETFs and ...

U.S. stocks inched higher by midday Wednesday, as traders weighed geopolitical uncertainty and awaited the Federal Reserve's ...

CMG's sales weakness is due to industry challenges, but with a plan to boost traffic and loyalty program, analyst maintains a ...

According to Benzinga Pro, Encompass Health's peer group average for short interest as a percentage of float is 5.19%, which ...

McDonald's lanza The Big Arch en Reino Unido, pero sus acciones cotizan en zona bajista y por debajo de la media de 200 días.

Plug Power shares fell Tuesday on fears of proposed clean energy tax cuts. The stock is now rebounding from the recent ...

Top U.S. regulators plan to reduce key capital requirements for the nation's largest banks. This move is expected to boost ...

Analysts expect the Richmond, Virginia-based company to report quarterly earnings at $1.17 per share, up from 97 cents per ...

Scholar Rock's apitegromab helped preserve muscle mass during tirzepatide-induced weight loss, improving overall body ...

A landmark stablecoin bill passed by the Senate is causing Circle's stock to surge. Investors are now betting on Circle to ...